| 2026-10-12 | Hochstufung | BofA Securities | Underperform → Buy |
| 2026-09-17 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-08-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-08-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-08-13 | Resumed | JP Morgan | Overweight |
| 2026-08-13 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-08-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-07-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-07-20 | Eingeleitet | CLSA | Hold |
| 2026-07-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2026-07-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2026-06-18 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2026-05-18 | Resumed | BofA Securities | Underperform |
| 2026-02-26 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-02-20 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-01-12 | Resumed | Goldman | Buy |
| 2025-12-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-14 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2025-09-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-08-26 | Bestätigt | Oppenheimer | Outperform |
| 2025-08-15 | Hochstufung | DA Davidson | Underperform → Neutral |
| 2025-06-05 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-05-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-04-21 | Herabstufung | DA Davidson | Neutral → Underperform |
| 2025-03-19 | Eingeleitet | Stephens | Equal-Weight |
| 2025-02-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-02-19 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-01-17 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-06 | Herabstufung | Guggenheim | Neutral → Sell |
| 2024-12-13 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-12-12 | Eingeleitet | Macquarie | Neutral |
| 2024-12-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-15 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-10-02 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2024-09-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-08-29 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-05-30 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-01-11 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-12-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-12-18 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-11-30 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-11-30 | Bestätigt | Needham | Buy |
| 2023-11-30 | Bestätigt | Oppenheimer | Outperform |
| 2023-10-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-15 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-31 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-01 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-02 | Hochstufung | Needham | Hold → Buy |
| 2023-01-20 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-18 | Eingeleitet | DA Davidson | Neutral |
| 2023-01-13 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2023-01-11 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-12-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-12-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-11-17 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-11-02 | Resumed | Macquarie | Outperform |
| 2022-10-17 | Eingeleitet | Northland Capital | Market Perform |
| 2022-09-28 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-09-02 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-08-12 | Eingeleitet | Guggenheim | Sell |
| 2022-05-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-03-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-03-02 | Bestätigt | BofA Securities | Buy |
| 2022-03-02 | Bestätigt | Canaccord Genuity | Buy |
| 2022-03-02 | Bestätigt | Piper Sandler | Overweight |
| 2022-03-02 | Bestätigt | Raymond James | Strong Buy |
| 2022-03-02 | Bestätigt | Stifel | Buy |
| 2022-03-02 | Bestätigt | UBS | Neutral |
| 2022-03-02 | Bestätigt | Wedbush | Outperform |
| 2022-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2021-11-22 | Resumed | Atlantic Equities | Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Buy |
| 2021-09-24 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-09-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-09-20 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-26 | Bestätigt | Barclays | Overweight |
| 2021-08-26 | Bestätigt | Bernstein | Mkt Perform |
| 2021-08-26 | Bestätigt | BofA Securities | Buy |
| 2021-08-26 | Bestätigt | Canaccord Genuity | Buy |
| 2021-08-26 | Bestätigt | Citigroup | Neutral |
| 2021-08-26 | Bestätigt | Cowen | Outperform |
| 2021-08-26 | Bestätigt | Credit Suisse | Outperform |
| 2021-08-26 | Bestätigt | FBN Securities | Outperform |
| 2021-08-26 | Bestätigt | Mizuho | Buy |
| 2021-08-26 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-08-26 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-26 | Bestätigt | Piper Sandler | Neutral |
| 2021-08-26 | Bestätigt | Stifel | Buy |
| 2021-08-26 | Bestätigt | UBS | Buy |
| 2021-07-16 | Resumed | Stifel | Buy |
| 2021-06-28 | Eingeleitet | Redburn | Buy |
| 2021-05-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-05-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-23 | Eingeleitet | Wolfe Research | Outperform |
| 2021-04-05 | Resumed | Credit Suisse | Outperform |
| 2021-03-16 | Resumed | Credit Suisse | Outperform |
| 2021-01-25 | Hochstufung | Loop Capital | Sell → Hold |
| 2021-01-22 | Eingeleitet | Goldman | Buy |
| 2021-01-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Resumed | BofA Securities | Buy |
| 2020-12-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-14 | Resumed | UBS | Buy |
| 2020-08-26 | Bestätigt | Barclays | Overweight |
| 2020-08-26 | Bestätigt | Citigroup | Buy |
| 2020-08-26 | Bestätigt | Cowen | Outperform |
| 2020-08-26 | Bestätigt | Credit Suisse | Outperform |
| 2020-08-26 | Bestätigt | JMP Securities | Mkt Outperform |
| 2020-08-26 | Bestätigt | Jefferies | Buy |
| 2020-08-26 | Bestätigt | Mizuho | Buy |
| 2020-08-26 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-08-26 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-08-26 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-26 | Bestätigt | Stifel | Buy |
| 2020-08-26 | Bestätigt | Truist | Buy |
| 2020-08-26 | Bestätigt | Wedbush | Outperform |
| 2020-08-24 | Bestätigt | Barclays | Overweight |